The Plus SideZ: A GLP-1 Guide to Metabolic Health cover art

The Plus SideZ: A GLP-1 Guide to Metabolic Health

The Plus SideZ: A GLP-1 Guide to Metabolic Health

By: Kim Carlos
Listen for free

Looking for real information on GLP-1 medications and weight loss? You’re in the right place.


The Plus SideZ Podcast is your go-to space for science-backed conversations about obesity treatment, weight loss, and living with a chronic metabolic disorder. Hosted by Kim Carlos and Kat Carter, we explore GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound, featuring insights from leading obesity specialists, endocrinologists, and bariatric surgeons. But this podcast is about more than just medication—it’s about navigating the mental, emotional, and physical journey of reclaiming your health.


We combat misinformation with education from top experts, helping you think critically about the latest research, treatment options, and systemic challenges in obesity care. And at the heart of it all are the powerful, vulnerable stories of our brave community members—people sharing their real experiences on GLP-1 medications, breaking stigma, and taking control of their health.


Ranked in the top 1% of podcasts globally, The Plus SideZ Podcast has won three awards in just 18 months, including two Anthem Awards for social impact. Featured on Good Morning America, Bloomberg News, and ABC Nightline on Hulu, we’re at the forefront of the conversation on weight loss, obesity care, and the fight to end weight bias.


Join us and be part of a movement that’s changing the way the world understands obesity, health, and metabolic wellness.


Our Linktree

https://linktr.ee/theplussidez


Want to donate?

PayPal
https://www.paypal.com/donate/?hosted_button_id=ZSEE2DRPHDSZN

GoFundMe
https://gofund.me/82c8138e

Shop The Plus SideZ Merch Store
https://the-plus-sidez-podcast.printify.me/products/1

Website
https://theplussidez.com/

© 2026 The Plus SideZ: A GLP-1 Guide to Metabolic Health
Hygiene & Healthy Living Personal Development Personal Success Physical Illness & Disease
Episodes
  • GLP-1 Medicare Coverage FAQ & Weight Loss Tips From Obesity Doctor
    Jun 23 2026
    Resources for the Community:___________________________________________________________________Linktree Our Favorite ThingsNeed help appealing your GLP-1 dials? www.FindHonestCare.com/KimFind Your US Representatives https://www.usa.gov/elected-officials ______________________________________________________________________Will Medicare finally expand access to GLP-1 medications for obesity? How do you qualify? In this episode, Kim and Kat are joined by community co-host Deb Cooperman and DeeDee, a 70-year-old GLP-1 patient, to discuss Medicare coverage, weight loss, maintenance, and life on GLP-1s after 60.Deb shares her experience paying cash for treatment while hoping to qualify for the new Medicare Bridge Program. DeeDee discusses maintaining her weight loss after losing access to medication, moving to compounded treatment, and growing up in a generation shaped by diet culture.Topics include:• GLP-1 medications after 60• Weight loss and maintenance• Medicare coverage and affordability• Diet culture and obesity• Long-term patient tips and lessons learned• Access to obesity treatmentObesity medicine specialist Dr. Michael Albert joins the conversation to answer common questions about Medicare coverage and the new Medicare Bridge Program, including:• Who qualifies• How the program works• How to apply• Options if you don't qualifyHe also discusses:• Weight loss with GLP-1s in older adults• Protecting muscle mass and prioritizing protein• Side effects to watch for• What to advocate for with your doctorWhether you're on Medicare, approaching eligibility, or helping a loved one navigate obesity treatment, this episode offers practical advice, patient perspectives, and expert guidance.Follow Guests Follow Deb https://www.instagram.com/thedebcooperman https://www.instagram.com/thedebcooperman Follow Dee DeeTikTok https://www.tiktok.com/@deesback Dr. Michael AlbertInstagram and TikTok: @michaelalbertmdWebsite: MichaelAlbertMD.com#GLP1 #Medicare #MedicareCoverage #ObesityMedicine #WeightLoss #HealthyAging #Zepbound #Wegovy________________________________________________________________________Join this channel to get access to perks: / @theplussidez______________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy #ObesityCare #PatientAdvocate #GLP1Community #RealGLP1StoriesSend us Fan Mail!Use Honest Care to Appeal GLP-1 Denials. Go to HonestCare.com/Kim Honest Care can Appeal GLP-1 Denials. Go to FindHonestCare.com/Kim Support the showKim Carlos, Executive Producer TikTokInstagram Kat Carter, Producer TikTokInstagram
    Show More Show Less
    1 hr and 31 mins
  • GLP-1 Stall? Why Your Body Stops Losing Weight | Dr. Michelle Gordon
    Jun 15 2026

    Resources for the Community:
    ___________________________________________________________________

    Linktree Our Favorite Things

    Need help appealing your GLP-1 denials?
    www.FindHonestCare.com/Kim

    Ro - Telehealth for GLP1 Weight Management


    GLP-1 Stall? Why Your Body Stops Losing Weight | Dr. Michelle Gordon

    Hosts Kim Carlos and Kat Carter talk with obesity medicine specialist Dr. Michelle Gordon about the biological factors behind a GLP-1 weight loss plateau. If you are on a medication like tirzepatide or semaglutide and the scale stops moving, it is driven by a complex neuroendocrine response.

    Dr. Gordon explains that the hypothalamus operates like a stubborn thermostat, defending a specific weight set point. When you lose weight, the brain reads the change as a threat and triggers physiological defenses. To prevent further weight loss, the body increases hunger hormones and simultaneously lowers its energy expenditure.

    Key topics include:

    • The Mechanism of a Stall: A weight plateau occurs at the exact point where your declining daily energy expenditure meets your rising natural hunger signals.
    • Menopause and Fat Oxidation: Midlife hormonal shifts cause fat oxidation to drop, which alters metabolic burn rates and shifts fat storage to the stomach.
    • The Chronic Disease Reality: Clinical data shows that stopping a GLP-1 medication typically results in regaining about two thirds of the lost weight, proving obesity requires continuous management.
    • Muscle Mass Preservation: Rapid weight loss from any method causes muscle loss, making strength training essential to preserve lean muscle and protect long-term functional health.

      Connect to Dr. Michelle Gordon:

      Substack: https://drmichellegordon.substack.com/

      Instagram: https://www.instagram.com/doctormichellegordon/

      Facebook: https://www.facebook.com/drmichellegordon/

      Practice Website: https://drmichellegordon.com/

      LinkedIn: https://www.linkedin.com/in/drmichellegordon/
      ______________________________________________________________________

      Join this channel to get access to perks:

      / @theplussidez
      ______________________________________________________________________

      #Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy #ObesityCare #PatientAdvocate #GLP1Community #RealGLP1Stories




    Send us Fan Mail!

    Support the show

    Kim Carlos, Executive Producer

    TikTok

    Instagram

    Kat Carter, Producer

    TikTok

    Instagram

    Show More Show Less
    1 hr and 4 mins
  • Debunking the *LIES* About GLP-1s (Ozempic Myths Overruled by Obesity Doctors)
    Jun 9 2026

    Linktree for Community Resources

    Need help appealing a GLP-1 Insurance Denial?
    FindHonestCare.com/Kim

    Ro - Telehealth for GLP1 Weight Management

    The Absolute Lies You’ve Heard About GLP-1s (Ozempic Myths Debunked) [REPLAY]

    Are you being lied to about Ozempic, Mounjaro, and Wegovy? In this special replay episode, leading obesity medicine specialists break down the biggest GLP-1 myths taking over your feed. We are reposting this crucial conversation because it is more relevant than ever. With GLP-1 price changes and expanding access options through federal programs like the Medicare GLP-1 Bridge, understanding the real science behind these medications is essential for patient advocacy.

    We are sharing a few favorite replay episodes right now while Kim is away on bereavement leave following the loss of her sister. We want to deeply thank our subscribers for staying engaged and supporting the show during this time.

    In this episode of The Plus Sidez Podcast, Kat joins Kim to sit down with obesity medicine specialists Dr. Matea Rentea and Dr. Ali Novitzki to help listeners better understand their disease and feel empowered in their healthcare journey.

    The Myths We Debunk:

    • The Muscle Loss Scare: The data behind weight loss and body composition, explaining why the medication itself is not destroying your lean mass.
    • The Willpower Narrative: Why obesity is a genetic, chronic metabolic disease rooted in brain biology, not a failure of personal willpower.
    • The Shot-Only Illusion: How the medication works alongside your body's natural satiety signals and gut receptors.

    Obesity Doctor Guidance Shared:

    • Metabolic Protection: A practical discussion on utilizing a 10-minute fitness routine and a 100-gram protein framework to maintain lean mass and support insulin sensitivity.
    • System Navigation: Insights on navigating insurance barriers, managing prior authorizations, and advocating for proper medical care.

    Mental Resilience: Tools to process unsolicited comments about your weight and protect your peace from societal judgment.


    Episode Topics:

    • Why We Are Replaying This Episode: Prices, Access, and Updates
    • The Insurance Landscape: Understanding Prior Authorizations
    • Meet the Obesity Medicine Specialists
    • Deconstructing the GLP-1 Muscle Loss Narrative
    • Strategies for Protecting Your Metabolism
    • What the Scales Do Not Show About Insulin Resistance
    • Natural Satiety Triggers and Gut Receptors
    • Recognizing Obesity as a Biological Chronic Disease
    • Addressing Weight Stigma and External Commentary


    Subscribe to The Plus Sidez Podcast for science-backed episodes breaking down metabolic health, body recomposition, and the truth about weight loss.

    Search Tags
    GLP1 lies debunked, Ozempic myths, Mounjaro weight loss journey, Wegovy truth, Zepbound body recomposition, insulin sensitivity hacks, natural GLP1 boosters, treating obesity metabolic disease, plus sidez podcast, dr matea rentea, dr ali novitzki
    _________________________________________________________________________

    Join this channel to get access to perks:
    https://www.youtube.com/channel/UC0HUIGKl3BN4Vg6LYI-dkOA/join

    _________________________________________________________________________
    #Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy

    Send us Fan Mail!

    Support the show

    Kim Carlos, Executive Producer

    TikTok

    Instagram

    Kat Carter, Producer

    TikTok

    Instagram

    Show More Show Less
    1 hr and 29 mins
adbl_web_anon_alc_button_suppression_t1
No reviews yet